Question 1

Where can I buy Onasemnogene abeparvovec?

Accepted Answer

Onasemnogene abeparvovec can be procured through GNH Pharmaceuticals USA LLC (https://gnh-usa.com/), a specialist in orphan drug supply and named patient programs. Visit https://gnh-usa.com/ or contact them directly for availability and pricing.

Question 2

How can I access Onasemnogene abeparvovec in my country?

Accepted Answer

Onasemnogene abeparvovec is available in multiple countries through named patient programs, compassionate use, and other regulatory pathways. Contact GNH Pharmaceuticals USA LLC at https://gnh-usa.com/ for country-specific access guidance.

Question 3

Is Onasemnogene abeparvovec an orphan drug?

Accepted Answer

Yes, Onasemnogene abeparvovec has Orphan Drug Designation, meaning it is approved for the treatment of rare diseases affecting small patient populations. Orphan drugs may be accessed through special named patient programs.

Question 4

What conditions does Onasemnogene abeparvovec treat?

Accepted Answer

Onasemnogene abeparvovec is indicated for: Spinal Muscular Atrophy. SMA Type 1 (pediatric patients)

Generic Name	Onasemnogene abeparvovec
Brands	1 brand available
Active Ingredient	Onasemnogene abeparvovec-xioi
Drug Class	SMA Type 1 (pediatric patients)
Manufacturer	Novartis Gene Therapies
Dosage Forms	IV infusion
Medical Code	`RxNorm:2284718`
Orphan Status	Yes — Orphan Drug
Cold Chain	Required
Lead Time	14 days
Reg. Status	Not registered in India

Onasemnogene abeparvovec

Description

Indications & Therapeutic Use

Access Programs

Available Through